Henry Schein Celebrates the Season of Giving
Henry Schein, Inc. (Nasdaq: HSIC), along with Team Schein Members (TSMs) from around the globe, is once again brightening the holiday season through its 26th annual “Holiday Cheer” program. This year, the initiative brought joy to over 1,150 individuals in…
Cardinal Health Begins Routine Actinium-225 Production at Theranostics Center
Cardinal Health (NYSE: CAH) has announced the initiation of weekly actinium-225 (Ac-225) production at its Center for Theranostics Advancement in Indianapolis, Indiana. This milestone follows a collaboration with TerraPower Isotopes and marks a significant step in expanding the availability of…
Superior HealthPlan Marks 25th Anniversary with $25,000 Grant to NAMI El Paso
Superior HealthPlan, a leading managed care organization in Texas and a subsidiary of Centene Corporation (NYSE: CNC), has awarded a $25,000 grant to NAMI El Paso in honor of its 25th anniversary. The grant will support mental health services for…
HCA Healthcare Appoints Wendy Warren as SVP & Chief Ethics Officer
HCA Healthcare, Inc. (NYSE: HCA), a leading healthcare provider in the United States, has announced the appointment of Wendy Warren as senior vice president and chief ethics and compliance officer, effective March 3, 2025. Warren, who has been with the…
Aetna Enhances Health App with Spanish Language Support
Aetna®, a CVS Health® company (NYSE: CVS), has enhanced the Aetna Health℠ app by adding Spanish language capabilities, aiming to improve access to care for Spanish-speaking health plan members nationwide. This update allows eligible members, regardless of their coverage type,…
Exicure Announces Approval of $8.7 Million Equity Financing and Executive/Board Changes
Exicure, Inc. (Nasdaq: XCUR, “Exicure” or the “Company”), today announced that its stockholders approved a second investment of $8.7 million from HiTron Systems Inc. (“HiTron”), a publicly listed company on the KOSPI exchange in South Korea. This approval was in…
Aptorum Group Reports 2024 Mid-Year Financial Results & Business Update
Aptorum Group Limited (NASDAQ: APM), a clinical-stage biopharmaceutical company focused on addressing unmet medical needs in oncology, autoimmune, and infectious diseases, today released its business update and financial results for the six months ending June 30, 2024. Business Update Aptorum…
Vertex Announces FDA Approval of ALYFTREK™ for Cystic Fibrosis Treatment
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced that the U.S. Food and Drug Administration (FDA) has approved ALYFTREK (vanzacaftor/tezacaftor/deutivacaftor), a once-daily, next-generation CFTR (cystic fibrosis transmembrane conductance regulator) modulator. ALYFTREK is approved for the treatment of cystic fibrosis (CF) in…
FDA Approves Pfizer’s BRAFTOVI® for First-Line BRAF V600E-Mutant Colorectal Cancer
Pfizer Inc. (NYSE: PFE) has announced that the U.S. Food and Drug Administration (FDA) has granted approval for BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) as a treatment for patients with metastatic…
JCR Pharmaceuticals Launches Phase III Trial of JR-142, Long-Acting Growth Hormone Therapy
JCR Pharmaceuticals Co., Ltd. (TSE 4552) today announced the dosing of the first patient in its Phase III clinical trial of JR-142 (INN: redalsomatropin alfa) in Japan. This marks a significant milestone for the company in the development of JR-142,…
ZIVO Bioscience Reports Early Efficacy of Proprietary Ingredients Against Avian Influenza
ZIVO Bioscience, Inc. (OTCQB: ZIVO), a leading biotech and agtech R&D company focused on developing therapeutic, medicinal, and nutritional products derived from proprietary algal cultures, has announced positive preliminary results from a recent study. Conducted in collaboration with the University…
Quantum-Si Unveils Advances in Protein Variant Detection with ProteoVue™ Software
Quantum-Si Incorporated (Nasdaq: QSI), known as The Protein Sequencing Company™, has announced the submission of a new preprint paper to BioRxiv, showcasing the power of its proprietary bioinformatics tool, ProteoVue, in detecting and quantifying Single Amino Acid Variants (SAAVs). The…